Arthneeti
Sale is live|00:00:00
Coromandel International LtdQ1 FY24

Coromandel International Ltd Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 1,971P/E: 27.6Market Cap: ₹58.5K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Specialty Nutrients (SND) expected to grow healthily by over 10-15%, with Rs. 600 Cr current turnover and plans to double sulfur production capacity (Page 11, 15).
  • Nano DAP product anticipated to see significant growth; potential to replace 20-25% of imported DAP over 3-4 years; commercial sales started recently with encouraging market response (Page 9, 10, 17, 18).
  • Retail business expanding rapidly, planning to open around 100 new stores in FY '25, targeting ~850 stores, including new markets like Tamil Nadu; achieved Rs. 1,700 Cr revenue previously (Page 10).
  • Crop Protection Chemicals (CPC) registering strong 20% volume growth; margin pressures expected to ease with new products and operational efficiencies (Page 4, 15).
  • Mining volume from Senegal expected to increase to 2.5-3 lakh tons aiding backward integration and operating leverage (Page 15).
  • Specialty Chemicals segment progressing; last year Rs. 50 Cr revenue with growth expected as capex and integration come online by FY '26-FY '27 (Page 14).
  • Drone business (Dhaksha) with Rs. 250 Cr order book for H1, potential for scaling revenues in FY '26-FY '27 (Page 8).

Margin guidance

Category 3
  • Fertilizer margins expected at Rs. 4,500 to Rs. 5,000 per ton in FY '25, driven by revised government subsidies and operational efficiencies.
  • Specialty Nutrient business projected to grow significantly, especially with the doubling of sulphur production capacity and Nano DAP expansion.
  • Non-subsidy businesses (including specialty chemicals, bio-products, and drones) targeted for healthy growth of 10-20% over next 2-3 years.
  • Specialty Chemicals capex of Rs. 1,200-1,500 Cr expected to start contributing revenue and profits by FY '27 after plant commissioning.
  • Retail segment and specialty nutrient distribution (SND) expected to grow over 10-15%, strengthening overall earnings.
  • Operational efficiencies from backward integration (e.g., Senegal mining, new sulphuric acid plant) to improve margins without price hikes.
  • Drone business (Dhaksha) expected to grow revenues with mid to high teens EBITDA margins as localization and scale improve.
  • Management focuses on margin expansion through cost optimization, product mix, and value-added products rather than price increases.

3 more insights locked — sign up free to unlock

Fundraise plans

  • The company currently holds a strong cash balance of over Rs. 3,000 Cr (cash and investments combined).
  • There is no mention of any immediate plans for new fundraising through debt or equity in the provided pages.
  • Cash is primarily intended to fund ongoing and planned capital expenditure programs, organic growth, and potential inorganic expansion.
  • The company is open to capital for further expansion and new opportunities, including specialty chemicals and CDMO, which may require future capex.
  • For now, the company appears to be focusing on utilizing existing cash reserves for capex and growth rather than raising new funds through debt or equity.

Order book

  • Dhaksha, Coromandel's drone business, has an order book of approximately Rs. 250 Cr.
  • The current order book is expected to be executed in the first half of the year.
  • As the logistic drone orders are completed, repeat orders from the government are anticipated.
  • The company is actively working on R&D for various types of drones beyond current offerings.
  • Coromandel is in advanced discussions with three innovator companies for CDMO services, expecting traction in 2-3 years.

Capex plans

Yes
  • FY '25 capex estimated at Rs. 1,200 Cr to Rs. 1,500 Cr across multiple businesses.
  • Major capex includes new Sulphuric Acid (SA) and Phosphoric Acid (PA) plants at Kakinada expected by FY '27.
  • Setting up multipurpose plants (MPPs) for crop protection chemicals at Ankleshwar and Dahej; expected 18-20 months for commissioning.
  • Debottlenecking granulation capacity by 3.5 lakh tons at Kakinada and Vizag.
  • Nano DAP facility commissioning pending government approvals.
  • Expanding retail stores by 100+ in FY '25, including new geographies like Tamil Nadu.
  • Investment in specialty chemicals, including fluorination chemistries and leveraging CPC plant assets.
  • Ongoing R&D and capacity build-up for Dhaksha drones; order book approx. Rs. 250 Cr.
  • Open to inorganic growth opportunities and capex for future expansions in specialty chemicals and CDMO segments.

How does Coromandel International Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature
1Coromandel International Ltd
Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Coromandel International Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio